Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
S55746
i
Other names:
S55746, S-55746, Servier-1, BCL-201, BCL201, Servier 1, S 055746, BCL 201, S 55746, S-055746, S055746
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
HitGen, Ligand, Novartis, Servier
Drug class:
Bcl2 inhibitor
Related drugs:
‹
venetoclax (416)
ABT 263 (19)
APG-1252 (8)
APG-2575 (7)
APG1244 (2)
BGB-11417 (2)
ABBV-167 (1)
AT 101 (1)
AZD0466 (0)
AZD4320 (0)
BGB-21447 (0)
BP1002 (0)
Bcl-2 Family Inhibitors (0)
FCN-338 (0)
FCN-683 (0)
oblimersen (0)
KLTi (0)
L105 (0)
LP-118 (0)
MRX34 (0)
S65487 (0)
SPC2996 (0)
TQB3909 (0)
TW-37 (0)
ZN-d5 (0)
LP-108 (0)
GX 15-070 (0)
PNT2258 (0)
ONT-701 (0)
ABBV-453 (0)
venetoclax (416)
ABT 263 (19)
APG-1252 (8)
APG-2575 (7)
APG1244 (2)
BGB-11417 (2)
ABBV-167 (1)
AT 101 (1)
AZD0466 (0)
AZD4320 (0)
BGB-21447 (0)
BP1002 (0)
Bcl-2 Family Inhibitors (0)
FCN-338 (0)
FCN-683 (0)
oblimersen (0)
KLTi (0)
L105 (0)
LP-118 (0)
MRX34 (0)
S65487 (0)
SPC2996 (0)
TQB3909 (0)
TW-37 (0)
ZN-d5 (0)
LP-108 (0)
GX 15-070 (0)
PNT2258 (0)
ONT-701 (0)
ABBV-453 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
S63845 + S55746
Sensitive: D – Preclinical
S63845 + S55746
Sensitive
:
D
S63845 + S55746
Sensitive: D – Preclinical
S63845 + S55746
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.